Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.57 -0.01 (-0.37%)
As of: Nov 11, 2026 · 9:30 AM EST

Galmed Pharmaceuticals (EOCN) Long-Term Debt Issuances (2013 - 2023)

Updated

Galmed Pharmaceuticals' Long-Term Debt Issuances came in at $130,000 for Q1 2023, down 25.7% from $175,000 a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Long-Term Debt Issuances (2013 - 2023) Analysis & Trends

Over the trailing twelve months to Mar 31, 2023, Galmed Pharmaceuticals reported Long-Term Debt Issuances of $8.24 million; for FY2022, it was $2.57 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Galmed Pharmaceuticals 2.06 Mn -38.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 130,000.00
Mar 31, 2022 175,000.00
Mar 31, 2014 7.26 Mn
Dec 31, 2013 675,000.00
API Access

Galmed Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=EOCN&period=max&api_key=YOUR_API_KEY